Menú

EMAP
Estudis en Medicaments en Atenció Primària (EMAP)

RESPONSABLE DEL GRUP
avatar_investigadors.jpg
Rosa Morros Pedrós
rmorros@idiapjgol.org
avatar_grups_recerca.png

Publicacions

Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-speranza COVID-19 Project study protocol

S. MONNE, F. CORDERO, G. MUNOZ, J. ORTEGA, S. MARTOS, O. PUERTOLAS, A. SANGENIS, R. PEDROS, R. PEDROS and M. GONZALEZ
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2022 May 1;

Veure més:
NSAIDs, analgesics and antiplatelet drugs and kidney function decline: A case control study

S. MONNE, B. GONZALEZ, M. SAEZ, C. URGELL, J. SANTOS, J. DIEZ, O. PUERTOLAS, J. RUIZ and R. PEDROS
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2022 May 1;

Veure més:
Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol (vol 23, 19, 2022)

F. MERA-CORDERO, S. BONET-MONNE, J. ALMEDA-ORTEGA, A. GARCIA-SANGENIS, O. CUNILLERA-PUERTOLAS, S. CONTRERAS-MARTOS, G. ALVAREZ-MUNOZ, R. MONFA, M. BALANZO-JOUE, R. MORROS and B. SALVADOR-GONZALEZ
Trials. 2022 Feb 9; . doi:10.1186/s13063-022-06073-7; PMID:35139906

Veure més:
Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol

F. CORDERO, S. MONNE, J. ORTEGA, A. GARCIA-SANGENIS, O. PUERTOLAS, S. CONTRERAS-MARTOS, G. MUNOZ, R. ESCOLA, M. JOUE, R. PEDROS and B. SALVADOR-GONZALEZ
Trials. 2022 Jan 6; . doi:10.1186/s13063-021-05951-w; PMID:34991703

Veure més:
Experiences prescribing medicines, alternative treatments and vaccines among health professionals in Catalonia (Spain): A qualitative study

B. MUNNE-BARELLAS, A. GARCÍA-EGEA, R. MORROS-PEDRÓS, C. VEDIA-URGELL, M. GINER-SORIANO and L. MEDINA-PERUCHA
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2024 Oct 1;

Veure més:

Patronat

Col·laboradors

Acreditacions